Sort
30,917 grants matching “tumor microenvironment”
Cancer Genomics: Integrative and Salable Solutions in R/Bioconductor
$704,932Martin T Morgan · Roswell Park Cancer Institute Corp · U24 · FY2020 · CA
Harnessing the power of exosomes for non-coding RNA delivery
$704,789Anil K Sood · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$704,749David P Carbone · Ohio State University · R01 · FY2024 · CA
Differential Inflammasome Regulation in the pathogenesis of S. aureus osteomyelitis
$704,729Deborah V Novack · Washington University · R01 · FY2023 · AI
Development of a platform for spatial functional genomics
$704,657Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AT
Preclinical studies for the immunoprevention of multiple myeloma
$704,622Peter Leif Bergsagel · Mayo Clinic Arizona · UG3 · FY2025 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$704,431Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
BONE MARROW MICROENVIRONMENT AND NEUROBLASTOMA PROGRESSION
$704,313Yves Declerck · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA
Understanding and targeting the DNA replication stress in cancer cells
$704,285Lee Zou · Massachusetts General Hospital · R35 · FY2021 · CA
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
$704,266Kenji Yokoi · Methodist Hospital Research Institute · U01 · FY2021 · CA
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
$704,248David J Beebe · University Of Wisconsin-Madison · R01 · FY2016 · CA
An organ on-a-chip model of oral cancer and bone invasion
$704,206Luiz Eduardo Bertassoni · Oregon Health & Science University · R01 · FY2025 · DE
LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS WITHIN TISSUE
$704,186Robert H Singer · Albert Einstein College Of Medicine · R01 · FY2011 · GM
Exploring PSMA Biology in Tumor neovasculature
$704,122Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$704,036Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$703,909Kwok Kin Wong · New York University School Of Medicine · U01 · FY2017 · CA
Project 4: MPN-RC Clinical Consortium
$703,869John Mascarenhas · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · CA
Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3
$703,595James K Turkson · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
$703,510Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
$703,381Levi Waldron · Graduate School Of Public Health And Health Policy · U24 · FY2023 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$703,320Benjamin G. Neel · New York University School Of Medicine · R01 · FY2021 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$703,320Benjamin G. Neel · New York University School Of Medicine · R01 · FY2025 · CA
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$703,315William C Hahn · Dana-Farber Cancer Inst · U01 · FY2015 · CA
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
$703,249Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Multinuclear MRI to Monitor Breast Cancer Therapy
$703,220Guillaume Madelin · New York University School Of Medicine · R01 · FY2023 · CA